Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Jiedu Tongluo Fang (补肾解毒通络方) is a traditional Chinese medicine (TCM) compound formulation, typically available as granules (颗粒剂). It is used as an adjunct therapy in the treatment of active rheumatoid arthritis and has also been studied for its effects on bone metabolism disorders associated with rheumatoid arthritis. The formula is designed to "tonify the kidney," "detoxify," and "unblock channels" according to TCM theory. Its mechanism of action involves modulation of inflammatory pathways and improvement of bone metabolism, potentially through downregulation of Hepcidin (Hepc), which may impact iron homeostasis and inflammation in rheumatoid arthritis[1][2][7]. Clinical studies have evaluated its efficacy when combined with standard Western medicines for improved outcomes in autoimmune joint diseases[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushen Jiedu Tongluo Fang.